Balixafortide

未知生产厂商

Balixafortide is under investigation in clinical trial NCT03786094 (Pivotal Study in HER2 Negative, Locally Recurrent or Metastatic Breast Cancer).

医学正文保留数据源原文，避免将未经专业审核的机器翻译呈现为临床事实。

概览

Balixafortide is under investigation in clinical trial NCT03786094 (Pivotal Study in HER2 Negative, Locally Recurrent or Metastatic Breast Cancer).

技术标识符

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。